ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Control Funds For Clinical Trials Intended To Upgrade Quality of Care: Terry

January 16, 1981

Wilmot Researchers Study Combination for Lymphoma

September 26, 2003

NCCN and Pfizer Issue RFP In Renal Cell Carcinoma Or Hematologic Malignancies

October 25, 2013

Group Chairs Urge NCI to Limit Authority of Steering Committees That Determine Which Trials Get Funded

August 5, 2011

Monica Bertagnolli To Succeed Schilsky As CALGB Chairman.

November 21, 2008

In Brief: ACCC Honors Henry Lynch; Gunderson Names Chair, Mayo Oncology Department

October 11, 1996